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License 4.0 (CC BY-NC).The local microenvironment limits the regenerative
potential of the mouse neonatal heart
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Neonatal mice have been shown to regenerate their hearts during a transient window of time of approximately
1 week after birth. However, experimental evidence for this phenomenon is not undisputed, because several labora-
tories have been unable to detect neonatal heart regeneration. We first confirmed that 1-day-old neonatal mice are
indeed able to mount a robust regenerative response after heart amputation. We then found that this regenerative
ability sharply declines within 48 hours, with hearts of 2-day-old mice responding to amputation with fibrosis, rather
than regeneration. By comparing the global transcriptomes of 1- and 2-day-old mouse hearts, we found that most
differentially expressed transcripts encode extracellular matrix components and structural constituents of the cyto-
skeleton. These results suggest that the stiffness of the local microenvironment, rather than cardiac cell-autonomous
mechanisms, crucially determines the ability or inability of the heart to regenerate. Testing this hypothesis by
pharmacologically decreasing the stiffness of the extracellular matrix in 3-day-old mice, we found that decreased
matrix stiffness rescued the ability of mice to regenerate heart tissue after apical resection. Together, our results iden-
tify an unexpectedly restricted time window of regenerative competence in the mouse neonatal heart and open new
avenues for promoting cardiac regeneration by local modification of the extracellular matrix stiffness.INTRODUCTION
Cardiovascular diseases are the leading cause of death in the developed
world (1), yet identifying a cure remains amajor unmetmedical goal.
Although recent investigations have shown that adult human cardio-
myocytes (CMs) can be replaced at a low but detectable rate (2), it is
well documented that large injuries to the adult heart culminate in
replacement of lost CMs with a collagen-rich scar (3). This response
results in a progressive deterioration of the heart contractile capacity,
ultimately leading to end-stage heart failure,which bears a poor prognosis
(3).Given the lackof therapeutic approaches to reverse the loss of functional
myocardium, the development of efficient and safe regenerative procedures
is an urgent need in the field of modern cardiovascular research.
Regeneration is a complex biological process by which animals
rebuild the shape, structure, and function of body parts lost after injury
or experimental amputation. In this context, adult zebrafish can exten-
sively restore CMs lost after surgical removal of a large portion of the
myocardiumwithin 60 days from the delivery of the injury (4, 5). In this
model, “de novo” tissue formation is accomplished through a series
of events that involve dedifferentiation of resident CMs and an increased
proliferation index (6–8). In 2011, Porrello and colleagues (9) observed
similar regenerative responses in the neonatal (1-day-old) mouse heart
after resection of a small portion of the left ventricular apex. After the
original report, several other laboratories also reported complete or
nearly complete regeneration after partial resection of the left ventricu-
lar apex in 1-day-oldmice (10–17). This ability to regenerate their hearts
was lost in 7-day-oldmice, in which amputation of the ventricular apex
was associated with scarring of myocardial tissue and hence a complete
lack of regeneration (9). Mouse CMs undergo a final round of DNAsynthesis without cytokinesis between postnatal days 5 and 7, withmost
CMs permanently withdrawing from the cell cycle (18, 19). Together,
these findings led to the assumption that CMs of newborn mice main-
tained their proliferative capability and hence the competence to regen-
erate lostmyocardial tissue during the first 7 days of life (9, 20), although
this assumed ability was never directly investigated.
Nonetheless, there have also been some discrepancies (21–23) as
to the regenerative ability of the neonatal mammalian heart since the
original study of Porrello et al. (9). For instance, Konfino and colleagues
(23) reported that heart regeneration in postnatal day 1 newborn mice,
after myocardial infarction in a model of left anterior descending artery
ligation,was incomplete andwas associatedwith the presenceof collagen-
rich deposits. However, later independent studies using the same car-
diac injurymodel reported complete scar-free cardiac regeneration (24).
More recently, Andersen and co-workers (21) found no evidence of
regeneration after performing an extensive study with long-term follow-
up involving apical resection of the heart ventricle in hundreds of neonatal
P1 mice from inbred and outbred strains. Other work independently
highlighted limitations in the degree of neonatal mouse heart regenera-
tion depending on the type and extent of the injury (22).
The molecular determinants of postnatal CM cell cycle withdrawal
are only partially understood. Several factors have been proposed to
promote CM cell cycle exit, including the transition from the hypoxic
intrauterine environment tomore aerobic postnatal conditions (25), up-
regulation of specific classes of microRNAs (20, 26), and the down- or
up-regulation of cell cycle regulators (27) and growth factors (28). Further
research is needed to clarify the extent and ability of postnatal CMs to
proliferate in response to heart injury, as well as to delineate the me-
chanisms underlying myocardial regeneration. Here, we investigated
the regenerative potential of the neonatal mouse heart by performing
amputation of the ventricular apex in mice at postnatal days 1, 2, 3,
4, and 9 (P1, P2, P3, P4, and P9, respectively). Our results confirm pre-
vious findings that P1neonatalmice display a robust cardiac regenerative
capacity in response to apex resection. Unexpectedly, heart amputation
in P2 animals induced an extensive fibrotic response and subsequent
scarring, similar to that observed in P3, P4, and P9 mice. Next, we1 of 12
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cues that could be responsible for the sharp decline in regenerative
potential between P1 and P2 mouse hearts. Differentially expressed tran-
scripts overrepresented gene categories involved in extracellular matrix
(ECM) composition. Then, we analyzed the mechanical properties of
the heart ECM by atomic force microscopy (AFM) and found that P2
hearts are significantly stiffer than P1. Finally, by decreasing the stiffness
of the local microenvironment with a pharmacological inhibitor of the
cross-linker enzyme lysyl oxidase (LOX), we were able to rescue the heart
regenerative competence of P3 mice. In summary, our combined results
identify a surprisingly narrow postnatal time window during which the
mouse heart retains the ability to regenerate after injury, and suggest
that changes in ECMstiffness and composition are novel and important
mechanisms to limit the ability of the mammalian heart to regenerate.RESULTS
Cardiac regeneration following apical resection in P1 mice
To determine whether apical resection of a small portion of the left
ventricle was associated with myocardial regeneration in mammals,
we first adapted to our laboratory the technique described by Porrello
and colleagues in 2011 (9) and detailed by the Sadek group in 2014 (29).
Our technique differed only in that the fixation step of the ventricular
heart section to be amputated was performed using a microsurgery
needle rather than blunt forceps (see Materials and Methods), a mod-
ification that facilitated accurate control of the amount of tissue resected
among individualmice and avoided the issue of surgically retracting the
heart (fig. S1A) (22).
Next, we investigated whether, in our hands, left ventricular apex
amputation in P1 mice was followed by robust tissue regeneration,
as previously reported (9). P1 mice displayed close to 80% survival
following apical resection, a survival rate moderately higher than that
reported in the original study (Fig. 1A). In response to the surgical am-
putation procedure, the hearts of P1mice (n = 46) underwent amarked
regenerative process. Stereomicroscopic investigation at 21 days post-
amputation (dpa) revealed that apically resected hearts displayed a size
and shape comparable to those of hearts from sham-operated siblings,
suggesting a hyperplastic rather than hypertrophic response to resection
(Fig. 1B). Given that the size of resected tissue had been used as an
argument to explain the disparate results obtained among different
laboratorieswith regard to the regenerative ability of the P1mouse heart
(22), we measured the resected area in a subset of amputated fragments
from P1 hearts using ImageJ software. From eight different measure-
ments, the relative area of resected tissue was comparable among
subjects (fig. S1B). At 3 dpa, the hearts of P1 mice exhibited a conspic-
uous injury, with the presence of disorganized myocardial fibers and
sign of acute inflammation (Fig. 1C, white arrowheads). Between 7
and 21 dpa, granulation tissue was gradually replaced by myocardial
tissue (Fig. 1C, black arrowheads). To evaluate the remodeling process
throughout the injury site of the ventricular apex, we also evaluated six
trichrome-stained sections that comprised the entire injury area (as ex-
plained in Materials and Methods). We noticed the presence of blue
collagen-rich deposits in only two of the six regions spanning the injury
site (fig. S1C). Quantification analysis of consecutive trichrome-stained
heart sections confirmed a near-complete regeneration of the P1 heart
(Fig. 1C). Finally, examination of troponin-I immunolabeled heart
sections at 7 and 21 dpa revealed that the area bordering the resection
plane contained CMs with dividing nuclei and intercellular spaces,
consistent with an infiltration of newly generated CMs (Fig. 1D). Quan-Notari et al., Sci. Adv. 2018;4 : eaao5553 2 May 2018titative real-time polymerase chain reaction (qRT-PCR) demonstrated
an extremely low expression level of atrial natriuretic peptide (Nppa)
(fig. S1D) and almost undetectable expression of brain natriuretic
peptide (Nppb), two important biomarkers with an established role
in heart failure (30), in P1 amputated organs as compared with sham
siblings at 21 dpa. These results suggest the absence of a maladaptive
remodeling process of the myocardial tissue and the mounting of a
tissue regenerative response.
One fundamental hallmark of myocardial regeneration is the cell
cycle reentry of spared CMs (18, 31). To determine whether our in vivo
amputation model stimulated cell cycle activity of resident CMs in P1
hearts, animals were pulsed with 5-bromo-2′-deoxyuridine (BrdU) fol-
lowing the apical resection procedure (fig. S1E). Nuclei cell division was
assessed by BrdU and troponin-I co-immunostaining, with quantifica-
tion of the number of proliferatingCMs [4′,6-diamidino-2-phenylindole
(DAPI)/Tnni3+/BrdU+] at 3, 7, and 21 dpa (fig. S1F). Statistically sig-
nificant (P < 0.005) higher numbers of proliferating CMs were found
in apically resected P1 hearts compared with sham hearts at 3, 7, and
21 dpa, both at the site of resection and at a distance from it (Fig. 1E).
These data demonstrated that the mouse P1 heart is capable of moun-
ting a robust myocardial regeneration response by enhancing the basal
turnover rate of resident CMs.
Fibrotic response after heart amputation in P2 mice
We next subjected P2 mice (n = 95) to our apical resection technique.
About 75% of P2 neonates survived the surgical procedure, withmater-
nal cannibalization only slightly affecting the survival rate by further
lowering this to 66.4% (Fig. 2A). Unexpectedly, stereomicroscopic ex-
amination of the apically resected P2 hearts at 21 dpa demonstrated the
presence of white fibrotic patches in the external ventricular wall (Fig. 2B,
black arrowheads). Over the time course of the study, amputated P2
hearts consistentlyweighed less than those fromshamsiblings, suggesting
a lack of myocardial tissue regeneration (Fig. 2C). Histological analysis
of serial sections at 21 dpa revealed evident signs of cardiac remodeling
with increased interstitial fibrosis, which was confirmed by quantifica-
tion analysis of the scar area in serial trichrome-stained heart sections
(Fig. 2D). To exclude the possibility of a delayed regeneration process in
P2mice, we extended the examination period of tissue sections to 35 dpa.
However, fibrotic deposits were still present at that time (fig. S2A). To
assesswhetherCMswerepresent in the repaired tissue regionof P2hearts,
we performed immunofluorescence staining for cardiac troponin-I. The
cardiac protein was not detected at any of the stages of the myocardial
repair process within the remodeled tissue, despite the presence of cell
infiltration in the area as demonstrated by DAPI staining (Fig. 2E), and
wasmore evident in higher-magnification images of these sections at
21 dpa (fig. 2B). These data indicate that hearts of 2-day-old mice
responded to amputationwith fibrosis rather than regeneration.No sta-
tistical differences in the expression levels of Nppa and Nppb were ob-
served between amputated and sham-operated hearts at 21 dpa (fig.
S2C). On the other hand, the expression level ofCol3a1, important com-
ponent of fibrous connective tissue (32), in amputated heartswas higher
at 21 dpa when compared to sham siblings (fig. S2D), suggesting an
active deposition of newly synthesized ECM. Next, we investigated CM
proliferation in BrdU pulse-chase experiments on P2mice (fig. S2E).
Hearts were obtained at 3, 7, and 14 dpa to assess CM proliferation by
colocalization of BrdU and a cardiac-specific antibody against myosin
heavy chain (MF-20) (fig. S2F). No statistically significant differences
were detected on the numbers of BrdU+ CMs in amputated relative to
sham-operated hearts at 3, 7, or 14 days after resection. Moreover,2 of 12
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number in both experimental groups (Fig. 2F).
Inconsistent results between laboratories with regard to the regen-
erative ability of the postnatal mouse heart had been partially justified
on the basis of the relative size of resected tissue (22, 23). Therefore, weNotari et al., Sci. Adv. 2018;4 : eaao5553 2 May 2018compared the heart–to–bodyweight ratio betweenP2 amputated (n=6)
and sham-operated (n = 4) mice 3 hours after surgery to calculate the
relative percentage of amputatedmyocardial tissue in these experiments.
Our calculations showed a consistent reduction of ~13% of weight in
amputated hearts relative to that of sham-operated hearts (fig. S2G).Fig. 1. Regeneration of the heart in P1 mice following surgical resection of a small portion of the left ventricular apex. (A) Survival of P1 mice that underwent
apical amputation (AMP; n = 46) or not (SHAM; n = 31). Animal survival was determined immediately (0 h), after 3 hours (3 h), and the day after surgery (24 h). Means ±
SEM. (B) Stereomicroscopic pictures of AMP and SHAM hearts at 21 dpa showed similar heart morphology with only minimal fibrosis evident in the external ventricular
wall (black arrowheads). (C) Representative hematoxylin and eosin (H&E)– and trichrome-stained sections of the apex of resected hearts at various stages of regenera-
tion. Cardiac tissue loss is evident at 3 and 7 dpa by the misalignment of tissue fibers (H&E inset) and by the presence of blue staining evidencing collagen deposition
(trichrome stain inset). Notably, at 21 dpa, fiber misalignment and blue collagen deposits were evident only in tissue outside the ventricular wall. White arrowheads
indicate acute inflammation, and black arrowheads indicate granulation tissue, whereas the dashed line marks the lesion border. Scale bars, 50 mm. Right: Quantification
analysis of the scar area in P1 AMP versus SHAM at 21 dpa. (D) Immunofluorescence staining for troponin-I and DAPI at 3, 7, and 21 dpa. An asterisk indicates the
healing area, whereas the dashed line marks the lesion border. Scale bars, 25 mm. (E) Number of proliferating CMs (DAPI+/Tnni3+/BrdU+ cells) per 0.1 mm2 counted in
paraffin-embedded SHAM (n = 3) and AMP (n = 5) heart sections from BrdU multiple pulse-chase experiments at the indicated dpa. Data are means ± SEM. Only fields
completely filled with cells were included in the analysis. *P < 0.05; **P < 0.01; ***P < 0.001.3 of 12
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heart tissue, a value that was previously associatedwith full regeneration,
at least in P1 mice (22). Moreover, quantification of the resected area
using imaging software further supported the consistency of our tech-
nique and reproducibility of our data (fig. S2H). Together, these data
show that amputation of the left ventricular apex in P2 neonatal mice
induced a healing response characterized bymassive fibrotic deposition,
which resulted in substantial scarring of the heart, in sharp contrast with
the regenerative response observed in P1 neonatal mice.Notari et al., Sci. Adv. 2018;4 : eaao5553 2 May 2018Absence of heart regeneration in P3 and older mice
Amputation of the left ventricular apex in P3 (n = 18) and P4 (n = 5)
neonatal mice resulted in fibrotic responses similar to those observed in
P2animals. InbothP3andP4groups, only about60%ofneonates survived
the surgical procedure (fig. S3A), despite the fact that the relative area of
resected myocardial tissue was comparable with that of experiments
performed in P2mice (fig. S3B).When analyzed at 21 dpa, visible white
patches on the external ventricularwall, corresponding to fibrotic deposits
in both groups, were observed (fig. S3C, black arrowheads). At theFig. 2. Scar and new myocardial tissue assessment following surgical amputation of the left ventricular apex in P2 mice revealed a lack of myocardial
regeneration. (A) Survival of P2 mice that underwent amputation (AMP; n = 91) or not (SHAM; n = 51) of a small portion of the left ventricular apex. Animal survival
was determined immediately (0 h), after 3 hours (3 h), and the day after surgery (24 h). Data are means ± SEM. (B) Stereomicroscopic pictures of AMP and SHAM hearts
at 21 dpa demonstrated the presence of extensive white patches on the external ventricular wall 21 days following surgery (black arrowheads). Scale bar, 1 mm. (C) Heart
weight of P2 AMP (n = 3) and SHAM (n = 3) mice was determined at different time points following surgery. (D) Representative H&E- and trichrome-stained sections of P2
hearts at 21 dpa. Cardiac tissue loss is evident by the misalignment of tissue fibers (H&E inset) and by the presence of intense blue staining (trichrome inset). Dashed line
marks the lesion border. Scale bar, 200 mm. Right: Quantification analysis of the scar area in P2 AMP versus SHAM at 21 dpa. ***P < 0.001. (E) Paraffin-embedded resected P2
hearts were sectioned and immunostained for troponin-I and DAPI. Representative images at various time points during the post-AMP process demonstrate an absence of
newly formed myocardial tissue. An asterisk indicates the healing area, whereas the dashed line marks the lesion border. Scale bar, 25 mm. (F) Number of proliferating CMs
(DAPI+/MF-20+/BrdU+ cells) per 0.1 mm2 counted in paraffin-embedded SHAM and AMP heart sections from BrdU multiple pulse-chase experiments at the indicated dpa. Data
are means ± SEM; n = 3. Only fields completely filled with cells were included in the analysis. ns, not significant.4 of 12
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deling of damaged myocardium with the presence of scar tissue and
collagen deposition at 21 dpa (fig. S3C, bottom), suggesting an ongoing
fibrotic response similar to the one seen in P2 hearts.
We also performed surgical amputation of the ventricular apex in P9
mice (n = 38). Survival of resected P9 mice was lower than 50%, in-
dicating that the surgical procedure was not well tolerated at this age
(fig. S4A). The surviving mice responded with evident fibrotic deposits
(fig. S4B, black arrowheads). At the histological level, all resected hearts
analyzed showed a considerable remodeling of the architecture of the
myocardial tissue with the presence of scar tissue and collagen deposi-
tion at 21 and 35 dpa, as shown by trichrome-stained images of heart
sections (fig. S4, C and D). Immunofluorescence staining using an an-
tibody against troponin-I further corroborated the absence of CMs in
scar tissue at 21 dpa (fig. S4E). Furthermore, expression levels of Nppa,
Nppb, and Col3a1 were significantly increased in P9 amputated hearts
when compared to sham siblings at 21 dpa (fig. S4F), supporting an
ongoing hypertrophic maladaptive response.
Transcriptional profiling of P1 and P2 mouse hearts
To gain insight into the molecular factors responsible for the abrupt
decline in heart regeneration competence between P1 and P2 mice,
we first compared the transcriptome profile of control, uninjured hearts
of 1- and 2-day-old mouse neonates. For this purpose, we performed
RNA sequencing (RNA-seq) of nonmanipulated P1 and P2 ventricular
tissue (n= 3). As expected, because of the overall similarity of both types
of sample, most detected transcripts displayed comparable expression
levels in P1 and P2 hearts (~7800 genes). A small but consistent group
of transcripts showed differential expression (up- or down-regulation)
in P2 versus P1 hearts (192 and 159 gene products, respectively) (Fig. 3A
and fig. S5A; see also list of transcripts in Supplementary Dataset). We
validated the RNA-seq results bymeasuring the expression of randomly
selected (up- or down-regulated) genes by qRT-PCR analysis (fig. S5B).
We also measured the expression levels of specific ECM-related tran-
scripts identified as differentially expressed in our RNA-seq analysis, as
well as ofDag1 (encoding dystroglycan 1) andAgrin, two genes recently
described to regulate mammalian heart regeneration (15, 16). For this
purpose, qRT-PCR analyses were carried out on ventricular tissue RNA
from P1 and P2mice, using specific primers spanning exon-exon junc-
tions of the genes of interest. Increased expression of the ECM-related
genesMfap5,Aspn, and Itga6was found in hearts of P2 compared to P1
neonatal mice, whereas no differences were observed for Agrin orDag1
(fig. S5C), further validating the results of our RNA-seq analysis.
Enriched gene ontology (GO) term analysis of differentially expressed
transcriptsbetweenP2andP1mousehearts revealedanoverrepresentation
of genes related to ECM binding and assembly (Fig. 3B), such as col-
lagens V and VIII (Col5a3 and Col8a1), microfibrillar-associated pro-
tein 5 (Mfap5), decorin (Dcn), metalloproteinase with thrombospondin
motifs 5 (Adamts5), and thrombospondin-1 (Thbs1). In line with this,
genes that were also involved in integrin binding processes such as in-
tegrin b-6 (Itgb6), integrina-7 (Itga7), vitronectin (Vtn), and endothelial
molecule 1 (Esm1) displayed higher expression levels in hearts of P2
mice than in those of P1 mice. GO term analysis further revealed that
transcripts for proteins contributing to the structural integrity of the sar-
coplasm such as myosin-binding protein C (Mybpc1 andMybpc2), myo-
sin light chain kinase (Mylk4), myomesins 1 and 2 (Myom1 andMyom2),
and microtubule-associated protein tau 2 (Mapt) also showed a pro-
nounced up-regulation over the course of 24 hours, reflecting increased
organization and assembly of the CM cytoskeleton. Conversely, mRNAsNotari et al., Sci. Adv. 2018;4 : eaao5553 2 May 2018down-regulated in P2 hearts compared with P1 belonged to the family
of genes that functionwithin the acetyl coenzymeAmetabolic pathway.
Overall, the GO bioinformatic analysis of the transcriptional changes
that occur in the mouse heart between P1 and P2 revealed that the de-
veloping mammalian heart rapidly up-regulates ECM components, as
well as structural sarcomere genes.
Contrary to our initial expectations, GO term analysis did not reveal
differences in the expression of cell cycle regulators such as cyclin, cyclin-
dependent kinases (CDKs), and/or CDK inhibitors between P1 and
P2 hearts (Fig. 3B). However, this was consistent with the fact that P1
and P2 hearts contained similar percentages of cycling CMs (Fig. 3C).
Moreover, we also quantified the number of mono- and binucleated
CMs in P1 and P2 operated hearts at 3 and 7 dpa. We observed simi-
lar high percentages ofmononucleatedCMs in both P1 and P2 hearts at
3 dpa (P1, 80.7 ± 0.76%; P2, 77.5 ± 3.21%), as well as similar low per-
centages of binucleated CMs (P1, 19.2 ± 1.15%; P2, 22.4 ± 3.21%), in line
with a previous report (19). At 7 dpa, we found an increase in the per-
centage of binucleated CMs in both P1 and P2 hearts as expected, albeit
lower than previously reported (19), most likely due tomethodological
differences in the labeling/scoring techniques, but again, no statistically
differences were detected between the two experimental groups (Fig.
3D). Our cumulative results thus far indicate that the loss of regenera-
tive competence that takes place in the mouse P2 heart appears mech-
anistically unrelated to the postnatal switch in CM cell cycle dynamics.
Moreover, our transcriptomic analyses identify major changes in ECM
composition occurring concomitantly with the transition from regen-
eration competence to regeneration incompetence.
Rescue of heart regeneration competence after decreasing
ECM stiffness
To ascertain the effect of differentially expressed genes encoding ECM
components on the actual ECM composition, we first quantified the
levels of structural ECM components in protein extracts from P1 and
P2 ventricularmyocardial tissue, including collagen II, collagen IV, elas-
tin, and laminin. P2 hearts consistently expressed more ECM proteins
than P1 hearts (Fig. 4A). Next, we measured the overall stiffness of the
heart ECM in P1 and P2 mice by AFM quantification of decellularized
whole heart sections. P2 heart ECM was ~50% stiffer than that of P1
hearts (Fig. 4B). These findings suggest that cross-linking of ECM com-
ponents is important to regulate stiffness of the heart in vivo.
It has been shown that the expression levels of transcripts encoding
the ECM cross-linker enzyme LOX are developmentally regulated and
might modulate ECM stiffness in neonatal mouse tissues (33). More-
over, pharmacological inhibition of LOX using 3-aminopropionitrile
(BAPN) was shown to reduce lung ECM stiffness in newborn mice
(34). Hence, to determine whether changes in ECM stiffness could
influence the regenerative capacity of neonatal mouse hearts in vivo, we
inhibited collagen and elastin cross-linking by treating mice with the
pharmacological LOX inhibitor BAPN (22). For this purpose, BAPN
was added to the drinking water of pregnant mice from 5 days post-
coitum (dpc) until 3 days post-partum [BAPN is known to be secreted
into the breastmilk (34)]. Newbornmicewere then sacrificed at P3, and
their hearts were processed for immunofluorescence analysis of major
ECMcomponents, including collagens II and IV, fibronectin, and lami-
nin. As expected, BAPN-treated hearts lost the fine network of collagens
II and IV but showed normal distribution of laminin and fibronectin
(Fig. 4C). ECM stiffness, directly measured by AFM in decellularized
slices of control and BAPN-treated P3 hearts, was significantly reduced
by~35% after treatmentwith the LOX inhibitor (Fig. 4D).Once verified5 of 12
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another series of experiments, we subjected control and BAPN-treated
P3 neonatal mice to amputation of the ventricular apex and analyzed
whether heart regeneration had occurred at 21 dpa (Fig. 5, A to C). In
agreement with our findings that P2 or older mice had lost the ability to
regenerate their hearts (see Fig. 2 and figs. S2 to S4), apical amputation
in untreated P3 neonatal mice resulted in extensive scarring and failure
to regenerate the amputated myocardium after 21 days (Fig. 5, A to D).
BAPN treatment prevented to a large extent the fibrotic response to in-
jury in apically resected P3hearts at 21 days after surgery (Fig. 5, A toD).
Quantification of Masson’s stained serial transversal sections of am-
putated hearts of control or BAPN-treated P3 neonatal mice at 21 dpa
confirmed that the damaged area was significantly reduced in the
BAPN-treated group when compared with the control one (Fig. 5, CNotari et al., Sci. Adv. 2018;4 : eaao5553 2 May 2018and D). We ruled out a direct effect of the BAPN treatment on the
CM proliferation rate by directly counting the numbers of MF-20/Ki67
double-positive cells, which showed no differences between control and
BAPN-treated P3 neonatal hearts (Fig. 5E). These data indicate that, by
decreasing the stiffness of the heart ECM in 3-day-old mice, we rescued
their ability to mount a regenerative response after apical resection.DISCUSSION
We have shown that P1 mice display a robust capacity to regenerate
their hearts upon experimental amputation of ~15% of the apex, thus
confirming the original findings by Porrello and colleagues (9). At
this point, the reasons behind the conflicting results obtained by others
(21, 35) are not entirely clear. In our studies, given that an inverseFig. 3. Differentially expressed genes in the ventricles of hearts from P1 and P2 mice. (A) Heat map showing the most differentially expressed (up- or down-
regulated) genes in individual hearts from P1 and P2 mice. Shaded color bar represents low (red) to high (green) expression level changes. (B) GO analysis of differ-
entially expressed genes between P1 and P2 hearts showing that the most differentially expressed genes belong to structural constituents of myoskeleton and of the
ECM. FDR, false discovery rate. (C) Left: Quantification of MF-20+/Ki67+ CMs at 1-day-old (P1) or 2-day-old (P2) newborn mice; n = 3. Right: Representative immuno-
fluorescence pictures of P1 and P2 heart sections display positive signal for myosin heavy chain (MF-20) and Ki67. DAPI was used to visualize CM nuclei. Black arrow-
heads indicate double-positive CMs. (D) Quantification analyses (%) of the mononucleated (MONO-) or binucleated (BI-) CMs at different time points during cardiac
regeneration carried on hearts of P1 and P2 mice.6 of 12
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tated tissue had been postulated (22), our surgical technique was pur-
posely designed to control for the amount of amputated myocardial
tissue among experiments and across the different age-dependent heart
sizes (figs. S1B, S2H, and S3B). Hence, we limited to less than 15% the
proportion of heart tissue amputated, the purported threshold above
which complete regeneration may not occur (22). We also carefully
timed our experiments with the time of parturition, thus ensuring that
pups used were exactly of the age reported (±3 hours). Given the
striking differences in the regenerative ability between P1 and P2 mice,Notari et al., Sci. Adv. 2018;4 : eaao5553 2 May 2018we speculate that age differences of more than 12 hours at this stage
could have a pronounced impact on the results. Therefore, it is plausible
that some of the differences reported in the regenerative ability of the
heart from newborn mice among studies could be related to actual age
differences between pups.
An unexpected finding of our studies is that the hearts of P2mice, in
sharp contrast with those of P1 neonates, do not regenerate in response
to experimental amputation. Experimentally convincing evidence as to
why or how the neonatal heart regenerates (whereas the adult one does
not) is for the most part missing. However, an intellectually satisfying
explanation of this fact posited that the heart’s regenerative ability was
related to the developmental window before CMs became binucleated
and withdrew from the cell cycle (9, 18, 25, 31). It had been shown that
most of the CMs in neonatal mice become postmitotic cells after P5 to
P7 (18). However, detailed analysis of myocytes isolated from neonatal
rat hearts suggested that, after P3, the number of myocytes in the heart
remained relatively constant (36), suggesting that hyperplastic growth
was almost complete at that time. Moreover, a careful analysis of DNA
synthesis and binucleation in CMs duringmurine development showed
amarked switch in these processes taking place between days 4 and 7
after birth (19). In agreementwith those findings, here, we did not detect
any differences in cell cycle or binucleation indexes between P1 and P2
hearts. Together, these data provide strong evidence disconnecting the
loss of regenerative competence in the mouse neonatal heart from the
postnatal switch in CM cell cycle dynamics. That is, if the regenerative
potential of the neonatal heart depended on CMs maintaining their
ability to proliferate, then it would be expected that neonates could re-
generate their hearts until postnatal days 3 to 5, as has been suggested
(9), but never experimentally addressed. However, our data show that
mouse hearts have lost their competence to regenerate as early as P2,
that is, long before the hyperplastic-to-hypertrophic transition takes
place (37). It should be noted that, although our data support the hy-
pothesis that the postnatal switch in CM cell cycle dynamics is not re-
sponsible for the loss of heart regenerative competence, our studies do
not resolve whether the responsible mechanisms involve the disappear-
ance of neonatal inductive signals for regeneration, the appearance of
barriers to regeneration in the adult, or both. Neonatal heart regenera-
tion is a complex phenomenon in which the response to injury is
superimposed on the background of normal development, making it
hard to tease both types of mechanisms apart. We trust that narrowing
down the window of time when the neonatal heart is competent for re-
generation will facilitate future research into this topic.
Our finding that P1 and P2 mouse hearts, in spite of their close
similarities in size, developmental state, and overall cell cycle profile, ra-
dically diverge in their regenerative potential provides an immediate ex-
perimental opportunity for addressing themolecular bases ofmammalian
heart regeneration. Comparative transcriptomic analysis of whole P1
andP2heart ventricles attested to the overall resemblance between these
two developmental stages, with more than 95% of detected transcripts
being similarly expressed (fig. S5A). However, we did detect a small
number of differentially expressed genes. Specifically, 1.9% of all de-
tected transcripts were found to be expressed at significantly higher levels
in P1 than P2 hearts, whereas 2.4% of the transcripts showed higher ex-
pression in the hearts of P2 mice compared with those of P1 neonates.
Although further investigationwill be necessary to ascertain the function-
al relevance of these differentially expressed transcripts in the context of
heart regeneration, the results of our first analyses give new insights into
this process. Thus, a search for enriched GO categories within this data
set did not detectGO annotations related to cell cycle regulation, lendingFig. 4. P1 and P2 hearts show differences in the ECM expression and stiff-
ness; BAPN treatment reduced tissue stiffness in P3 mice. (A) Left: Protein
levels of ECM components were detected in ventricular heart tissue of P1 and
P2 mice by immunoblotting using specific antibodies against collagen II, collagen
IV, elastin, and laminin. Junctional connexin 43 protein was used as a loading
control. A representative blot from three independent experiments is shown
for each panel. Notably, each panel was cropped to better illustrate the difference
between P1 and P2. Full-length blots are presented in fig. S6A. Right: Densitom-
etry analysis of three independent Western blot experiments. (B) Graph showing
the overall stiffness as measured using AFM in decellularized sections of P1 and P2
neonatal mouse hearts; n = 3. (C) Immunofluorescence showing the distribution of
collagens II and IV (top) and fibronectin and laminin (bottom) in heart sections of P3
mice after treatment with BAPN and in control littermates. Scale bars, 50 mm. (D) Graph
showing the overall stiffness as measured using AFM in decellularized sections of con-
trol and BAPN-treated P3 neonatal mouse hearts; n = 3. *P < 0.05, **P < 0.01.7 of 12
SC I ENCE ADVANCES | R E S EARCH ART I C L EFig. 5. Decreasing ECM stiffness rescues heart regeneration capacity of P3 mice. (A) Stereomicroscopic pictures of control or BAPN-treated P3 neonatal mouse
hearts at 21 dpa showed similar heart morphology, but fibrotic patches (black arrowheads) were much more evident in the external ventricular wall of control hearts.
(B) Representative trichrome-stained sections of control and BAPN-treated P3 neonatal mouse hearts at 21 dpa. Dashed lines mark the amputation plane. Scale bars,
200 mm. (C) Serial transverse sections of trichrome-stained hearts of two control and two BAPN-treated neonatal mice at 21 dpa. Collagen deposits are indicated by
black arrowheads. (D) Quantification analysis of the scar area in control and BAPN-treated P3 neonatal mice at 21 dpa; n = 3. (E) Left: Representative immuno-
fluorescence images of heart sections showing positive signal for myosin heavy chain (MF-20) and Ki67. DAPI was used to visualize CM nuclei. Black arrowheads indicate
double-positive CMs. Scale bars, 25 mm. Right: Quantification of proliferating CMs (MF-20+/Ki67+ cells) in control and BAPN-treated P3 neonatal mouse hearts before (0 dpa)
or at 21 dpa. Data are means ± SEM; n = 3. ***P < 0.001; ns, not significant.Notari et al., Sci. Adv. 2018;4 : eaao5553 2 May 2018 8 of 12
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the neonatal mouse heart is not limited by the proliferation ability of
CMs. In contrast, we detected significant enrichment of GO categories
related to ECM components and integrin binding, as well as structural
constituents of the cytoskeleton (Fig. 3B). These findings were further
corroborated through protein expression analysis for collagens II and
IV, elastin, and laminin—major components of the ECM (Fig. 4A).
It has been shown that the composition and mechanical properties
of cardiac ECM greatly vary during the transition from the intrauterine
environment to the postnatal life, and this has been mechanistically
linked with the appearance of heart disease (38). The elastic modulus
calculated in samples of developing ventricular tissue in rats showed
a clear discontinuity and immediate increase at birth (39), supporting
our hypothesis that local microenvironment may affect CM behavior
and so cardiac regeneration. No major changes have previously been
noted to occur between P1 and P2 mouse hearts to our knowledge.
Overall, the ECM is considered an important component of the heart
maturation process through either direct interaction with cells or
modulation via growth factor stimulation (40). Recent investigations
have demonstrated that the ECMprotein Agrin can act as a new inducer
of mammalian heart regeneration (15) and that the dystrophin glyco-
protein complex (DGC), a multicomponent transmembrane complex
linking actin cytoskeleton to the ECM, is essential for cardiac regenera-
tion, whereas the DGC component Dag1 inhibits cardiac regeneration
(16).However, we could not detect differences in the expression levels of
Agrin or Dag1 between P1 and P2 neonatal mouse hearts, making it
unlikely that these factors mediate the competence to regenerate in
this context. Mechanical properties such as stiffness and flexibility con-
stitute a third mechanism that may account for how the ECM controls
cell function (41, 42). Hence, rigid matrices facilitate nuclear division
(karyokinesis) leading to binucleation, whereas flexiblematrices pro-
mote CM mitotic rounding and cell division (cytokinesis) (43). Along
these lines, our results indicate that important changes in ECM stiffness
take place in the mouse heart between P1 and P2. However, the mech-
anisms by which those changes affect neonatal mouse heart regenera-
tion donot appear to involve differences inCMdivision or binucleation,
whichwe showare comparable in P1 andP2mouse hearts (Fig. 3, C and
D). Nevertheless, the fact that experimental manipulation of the ECM
cross-linking to reduce its stiffness partially restores the regenerative
competence of P3 mouse hearts provides evidence in favor of a causal
link between the two processes. Overall, our results are compatible with
a scenario inwhich themarked changes in heart ECM stiffness that take
place in the neonatal mouse between postnatal days 1 and 2 are, at
least in part, responsible for the loss of regenerative ability. It is well
established that the ECMnot only stabilizes andmaintains the struc-
ture of tissues and organs but also can determine various cellular beha-
viors such as migration, adhesion, and proliferation. Further research
will be needed to dissect the exact mechanisms by which changes in
ECM stiffness mediate the loss of regeneration competence in the
mouse neonatal heart.
The key to understanding the regenerative potential of the mamma-
lian heart lies within the developmental transitions occurring during the
first few days of neonatal life. In this regard, the ability of the immature
mammalian heart to regenerate and the subsequent loss of this potential
provide an important tool for understanding regeneration competence.
Our findings indicate a novel temporal window in which to study the
cellular and molecular processes leading to the limited regenerative
potential of the adult mammalian heart. Moreover, our data point at
the microenvironment and its varying stiffness as a novel mechanismNotari et al., Sci. Adv. 2018;4 : eaao5553 2 May 2018that influences myocardial regeneration competence. Understanding
these processes in detail will help to identify regeneration inductive
factors and/or development-associated regeneration constrains and
generate new targets for therapeutic manipulation.MATERIALS AND METHODS
Animals
Eight-week-old female and male ICR/CD1 mice were purchased from
Charles River Laboratories España S.A. and bred according to routine
guidelines. Animals were housed in individually ventilated cages in a
12-hour/12-hour light/dark cycle and fed ad libitum. All animals were
handled according to Institutional Animal Care and Use Committee
guidelines. All procedures involving animals were approved by and in
accordancewith theAnimal in Science RegulationUnit at theGeneralitat
deCatalunya (Spain), and the following procedureswere approved by the
Ethical Review Committee of the Barcelona Biomedical Research Park
(PRBB) Animal Committee.
Ventricular apex resection procedure
The left ventricular apex resection procedure used here is diagrammed
in fig. S1A. With pups anesthetized by hypothermia, apical resection
was performed after lateral thoracotomy at the fourth intercostal space
and dissection of the intercostal muscle (fig. S1A). Differences between
our procedure and that previously described lie in the fact that we gently
lifted the left ventricular apex upward using a needle inserted above the
portion to be resected. Then, we excised the portion ofmyocardial tissue
immediately below the needle using micro-ophthalmic scissors (fig.
S1A). By inserting themicrosurgery needle in the sameposition for each
amputation, we were able to ensure a reproducible procedure with re-
gard to the location and size of resected myocardial tissue (figs. S2A
and S3B). This is important because the size of amputated tissue was a
potential source of discrepancy that could explain the different results
reported by previous groups (22). Apical resection surgery was per-
formed on postnatal days 1 (P1), 2 (P2), and 9 (P9). Mating pairs were
monitored daily and separated once a plug was detected. Following
19 days, pregnant females were monitored every 12 hours for birthing
to allow for accurate aging of newborn pups and timing of the surgical
procedure. For surgery, neonates were anesthetized by inducing hy-
pothermia on ice. For amputation, anesthetized neonatal mice were
immobilized under a stereomicroscope and subjected to a lateral thor-
acotomy incision at the fourth intercostal space to expose the heart. A
microsurgery needle was used to gently fix in place the apex of the heart.
Amputation of a small portion of the ventricular apex was performed in
one single cut using angled iridectomy scissors. The thoracic wall inci-
sion was then sutured using a continuous pattern with 7-0 silk. Neonates
were then removed from the ice bed and placed on a heat pad for re-
covery. Pups were returned to their dam when spontaneous movement
and a red/pink complexion returned. From anesthesia induction to full
recovery, the entire procedure tooknomore than 10min. Sham-operated
mice underwent the same procedures with the exception of heart fixation
or resection. Following surgery, animals were checked every 24 hours
for 3 days, and any pups not recovering well from surgery or displaying
complications were euthanized. The postsurgical survival rate was also
recorded.
Heart tissue recovery
Sham-operated and apically resected hearts were harvested at different
time points following surgery. For this purpose, mice were euthanized9 of 12
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(>21 days of age). Hearts were carefully dissected, avoiding any fur-
ther damage, washed in phosphate-buffered saline (PBS)/heparin
(SAD, 5000 IE/ml), and then processed appropriately for further anal-
ysis. To determine the percent of heart amputated in our experiments, a
set of each six resected and sham-operated pupswereweighed following
surgery and before euthanasia. Then, hearts were resected and washed
in PBS/heparin (SAD, 5000 IE/ml) to flush out any residual blood from
ventricles. Following dissection of any noncardiac annexa and the atria,
the ventricles were carefully dried and weighed. Then, for each of the
pups, the heart–to–body weight ratio was calculated and then averaged
across resected and sham-operated mice, respectively. With sham-
operated mice given an arbitrary value of 1, the heart–to–body weight
ratio difference between the two groups ofmicewas used to estimate the
average percentage of heart that had been amputated. In addition, for
the same set of hearts, the piece of amputated myocardium was photo-
graphed under a stereomicroscope, and the area of each piece was
calculated in arbitrary units using ImageJ software.
Histological analyses
Mouse hearts at various stages following surgery were dissected as
above and processed for histological examination. We noticed that a
weak superficial adhesion often formed between the pericardium and
pleural surface of the chest wall in animals having undergone apical re-
section. This was carefully dissected to avoid leaving any heart tissue
behind. Mice sacrificed at 21 dpa were previously injected with 20 ml
of heparin (50,000 U/ml) to prevent blood clot formation. Dissected
hearts were rinsed in warm PBS, blotted on 3MM paper to remove
excess fluid, weighed, and then fixed overnight in 2%paraformaldehyde
at 4°C. After washing, hearts were embedded whole in paraffin and
sectioned.We performed consecutive serial 5-mm-thick sections that
spanned throughout the injured area of the heart. Every 10 sectionswere
consecutively placed on a different glass slide for staining and evaluation.
Ultimately, each glass slide contained six sections that represented con-
secutive three-dimensional regions across the injured area 50 mm apart.
Therefore, for each staining performed, this permitted a thorough eval-
uation of any changes spanning the entire region of interest.
Masson’s trichrome andH&E staining were performed on depar-
affinized heart sections according to the manufacturer’s instructions
(Sigma-Aldrich). Images were analyzed using ImageJ software, and the
extent of scarring was calculated as the area of fibrotic infiltration (blue
color inMasson’s trichrome staining) across the injured area. For immu-
nofluorescence, sections were deparaffinized and rehydrated before an-
tigen retrieval (DAKO REAL solution, pH 9). Blocking was performed
(1 hour) in a solution of 1× tris-buffered saline supplemented with 0.5%
Triton X-100 and 3% donkey serum, and tissue sections were incubated
overnight at 4°C with mouse monoclonal antibodies MF-20 (1:2 dilu-
tion; Developmental StudiesHybridomaBank at theUniversity of Iowa)
and fibronectin (1:250 dilution; L0791, Sigma) or with rabbit polyclonal
antibodies against troponin-I (1:25 dilution; sc15768, Santa Cruz Bio-
technology), collagen II (1:250 dilution; Ab34712, Abcam), collagen
IV (1:250 dilution; Ab6586, Abcam), Ki67 (1:25 dilution; RM91-06-S,
Thermo Fisher Scientific), or laminin (1:100 dilution; L9393, Sigma)
or with rat polyclonal antibody against BrdU (1:25 dilution; OBT0030,
Accurate Chemical and Scientific Co.). This was followed by incubation
with the corresponding Alexa Fluor–conjugated secondary antibodies
(1:200 dilution; Molecular Probes) for 2 hours at 37°C. Sections were
then stained with DAPI (Invitrogen), mounted, examined, and photo-
graphed using a Leica TCS SP5 AOBS spectral confocal microscope.Notari et al., Sci. Adv. 2018;4 : eaao5553 2 May 2018In vivo BrdU pulse-chase labeling experiments
Apically resected (n = 5) and sham-operated (n = 3) neonatalmice were
injected subcutaneously with 50 ml of a solution of BrdU (20 mg/ml;
Roche Applied Science) at different days after surgery (see figs. S1E
and S2E). The hearts were then harvested at different time points fol-
lowing surgery andprocessed histologically as described above. For each
heart, we averaged the number of Tnni3+/BrdU+ or MF-20+/BrdU+
cells across four fields of view randomly chosen around the injured area
(border zone) or at a distant area within the left ventricle (remote zone)
for four different planes of section across the entire injured area of the
apex. To assess CM proliferation in experiments involving P1 neonates,
a 100-mm × 100-mm grid (10,000 mm2) was laid over images, taken at
×63 magnification, of each amputated or sham-operated heart, ana-
lyzing an average of four different planes of sections within the apex
of each heart, and the number of BrdU+/Tnni3+ cells within that area
was counted. To count proliferating CMs in experiments involving P2
neonates, the number of MF-20+/BrdU+ cells was calculated in consecu-
tive images, taken at ×40magnification, spanning a total area of 0.1mm2.
For both P1 and P2 hearts, only fields completely filled with cells were
included in the analysis. DAPI was used to counterstain nuclei and
helped to distinguish mono- and binucleated CMs. Representative
images were taken at ×63 magnification for P1 hearts and at ×40 mag-
nification for P2 hearts.
Treatment with BAPN and heart decellularization
For BAPN treatment, we designed a protocol based on previously re-
ported regimes of oral administration in adult (44) and neonatal (34)
mice. In brief, pregnant 6- to 10-week-old female CD1 mice were trea-
ted with BAPN (1 mg/ml; in drinking water) for 17 days, beginning on
the fifth dpc and ending on the third day post-partum. The volume of
drinking water consumed was monitored weekly to assess the average
dose of BAPN ingested by the mice, which amounted to ~5 mg of
BAPN per mouse per day (~125 mg/kg per day). For decellularization
experiments, hearts were harvested without great vessels and atria,
quickly placed in warm (37°C) PBS to allow the blood to leave the ven-
tricle chamber, snap-frozen using liquid N2, and stored at −80°C until
use. Hearts underwent three cycles of freeze/thawing to damage the
cellular membrane. To keep a similar size and weight of the myocardial
tissue to be decellularized in between different mouse ages, a similar
slice in weight of myocardial tissue was cut for all the hearts analyzed.
Myocardial organs were decellularized in autoclaved 2-ml Eppendorf
tube in the orbital shaker (GyroMini) with decellularized buffers
(0.2% Triton X-100, 0.4% Triton X-100 in PBS, and 25 mM EDTA)
for 24 hours. After decellularization, hearts were washed using PBS
and finally water. We then cryosectioned and analyzed the structure
by immunofluorescence analysis, by various colorimetric techniques,
or by AFM.
Atomic force microscopy
Mechanical measurements were carried out with a custom-built atomic
force microscope (TE2000, Nikon). Measurements were performed at
room temperature with four-slide pyramidal tips attached to cantilevers
with a nominal spring constant (k) of 0.03 N/m (MLCT, Bruker). To
compute the effective Young’s modulus of the ECM, 10 force
displacement curves (F-z) were recorded at 1 Hz with a peak-to-peak
amplitude of 5 mm. In hearts, measurements were taken in three differ-
ent regions of the ventricles, corresponding to pericardium,myocardium,
and endocardium. The regions of interest for AFMmeasurements were
identified bymeans of phase-contrast images recordedwith the inverted10 of 12
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were taken in five separated by 10 mm.
Quantitative real-time PCR
Total RNA was extracted from only the ventricles of different hearts at
various days after apical resection surgery. Briefly, samples were treated
in TRIzol reagent, and total RNA was extracted using the miRNA
Easy Kit (Qiagen) following the manufacturer’s instructions. For com-
plementary DNA (cDNA) synthesis, 25 or 50 mg of total RNA was
reverse-transcribed using the ClonedAMVFirst-Strand cDNASynthesis
Kit (Invitrogen), and all qRT-PCRs were performed in technical tripli-
cates. Detection of different PCRproducts wasmonitored bymeasuring
the increase in fluorescence caused by the binding of SYBR Green dye.
All qRT-PCRs were run with an Applied Biosystems 7900 HT Fast
qRT-PCRSystem thermocycler following themanufacturer’s instructions.
The qRT-PCR data were obtained by normalizing the raw data against
two stably expressed endogenous control genes (Gapdh and Rlp13), as
determined by the DCt method.
RNA-seq and analysis
Total RNA was extracted from only the ventricles of P1 (n = 3) or P2
(n = 3) hearts using QIAzol lysis reagent (Qiagen) and RNeasy extrac-
tion kit (Qiagen) according to the manufacturer’s instructions. Poly-
adenylated RNA was isolated from 1 to 5 mg of total RNA using the
Dynabeads mRNA Purification Kit (Invitrogen). Polyadenylated RNA
was then fragmented, retro-transcribed, and finally resynthesized to
double-stranded DNAmolecules using DNA polymerase I (Invitrogen).
End-pair, A-tailing, adapter ligation, and size selection were then per-
formed. RNA-seq analysis was performed using the 50-nucleotide-long
paired-end reads obtained from sequencing six samples of mouse heart
tissue at two different time points and using three biological replicates
for each time point. First, the quality of the reads was verified using
FastQC v0.11.21. Then, the reads were mapped toMusmusculus ref-
erence genome vGRCm38 2, using TopHat v2.0.143. Following map-
ping, the transcript and normalization counts were performed using
Cuffdiff v2.2.1 4. The differential expression analysis of normalized
counts was performed using cummeRbund v2.12 5, a widely used
R v3.2 package that works together with the Cuffdiff software; the ap-
plied threshold on the parameter a in the function getSig of the package
was≤0.05. Last, the differentially expressed genes were visualized using
the heat map.
Statistical analysis
All data obtained from various experiments followed a normal dis-
tribution and were analyzed using an unpaired two-tailed t test. All data
aremeans±SEM. Statistical analyseswere carried out using theGraphPad
Prism software.SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/4/5/eaao5553/DC1
fig. S1. Procedure for resection of the left ventricular apex in neonatal mice and long-term
effects of amputation surgery in P1 and older mice.
fig. S2. Scar and new myocardial tissue assessment following surgical amputation of the left
ventricular apex in P2 mice revealed a lack of myocardial regeneration.
fig. S3. Lack of regeneration following amputation of the left ventricular apex in P3 and
P4 mice.
fig. S4. Lack of regeneration following amputation of the left ventricular apex in P9 mice.
fig. S5. Differentially expressed genes in the ventricles of hearts from P1 and P2 mice.Notari et al., Sci. Adv. 2018;4 : eaao5553 2 May 2018fig. S6. Expression level of ECM proteins in P1 and P2 and relative size of resected tissue in
BAPN-related experiments.
Supplementary Dataset. List of transcripts differentially expressed in P1 and P2 neonatal
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